NIH-funded research Career grant

Improving electrical stimulation treatments for epilepsy

Official title: Optimization and mechanisms of electrical neurostimulation in mouse models of epilepsy

Funded at Washington University · NIH-10992162 · Data updated 2026-11-12

This study is looking at how to make electrical treatments for epilepsy work better for people whose seizures don't respond to medication, using mice to find the best ways to stimulate the brain.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startDecember 1, 2023
Project endNovember 30, 2028
Funding year2025
Award (this year)$232,981
NIH project number5K08NS126730-02
Project IDNIH-10992162 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from drug-resistant epilepsy who have not found relief from standard treatments.

Less likely to help

Patients with well-controlled epilepsy or those who do not have epilepsy may not benefit from this research.

What this research studies

This research focuses on enhancing the effectiveness of electrical neurostimulation therapies for patients with drug-resistant epilepsy. By studying mouse models, the project aims to understand how different stimulation parameters and electrode placements can optimize treatment outcomes. The research will explore the underlying mechanisms of neurostimulation to identify novel therapeutic effects that may alter the course of epilepsy. The principal investigator, Dr. Thomas Foutz, will work under the guidance of experienced mentors to develop skills in this innovative treatment approach.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for patients with epilepsy who do not respond to traditional medications.

How similar studies have gone: Previous research has shown promise in using neurostimulation for epilepsy, indicating that this approach has potential for significant advancements in treatment.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Foutz, Thomas — Washington University
  • Study coordinator: Foutz, Thomas

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.